{
  "symbol": "GUTS",
  "company": "Fractyl Health, Inc.",
  "generated_at": "2026-06-24T07:36:48.496Z",
  "event_count": 3,
  "events": [
    {
      "type": "pipeline_event",
      "ts": "2026-06-11T22:05:57.606Z",
      "stage": "analyst",
      "outcome": "skip",
      "reason": "The dossier flags a going-concern disclosure and accelerating cash burn with runway only into early 2027, creating a severe dilution and bankruptcy risk that overrides the clinical catalyst upside. As a pre-revenue small-cap biotech with a hard anti-signal gate and no earnings or positive quality metrics, it fails the publish threshold.",
      "trigger": "[insider_cluster_universe] 6 Form 4 filings in last 14 days · at least one open-market P/S trade verified",
      "source": "idle_hunter"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-06-11T22:05:57.571Z",
      "skip": true,
      "reason": "The dossier flags a going-concern disclosure and accelerating cash burn with runway only into early 2027, creating a severe dilution and bankruptcy risk that overrides the clinical catalyst upside. As a pre-revenue small-cap biotech with a hard anti-signal gate and no earnings or positive quality metrics, it fails the publish threshold.",
      "score": 14,
      "breakdown": {
        "smart_money": 3,
        "options_flow": 0,
        "catalyst": 8,
        "mispricing": 0,
        "quality": 0,
        "technical": 3
      },
      "debug_path": "drafts/2026-06-11-GUTS.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-06-11T22:04:58.418Z",
      "summary": "Fractyl Health is a clinical-stage metabolic biotech (obesity/T2D) with two programs: Revita DMR (endoscopic duodenal mucosal resurfacing for post-GLP-1 weight maintenance) and Rejuva gene therapy (pancreatic GLP-1 expression). The investigation was triggered by 6 Form 4 filings in the last 14 days. Of these, TWO are genuine open-market P/S buys: Director William Bradley purchased 68,493 shares at $0.7348 on June 10 ($50,329) and CFO Lara Smith Weber purchased 20,000 shares at $0.6854 on June 8 ($13,708). The remaining four filings from directors on June 10 were stock option grants (A code), not purchases — noise for the thesis. The stock trades at ~$0.72, down ~70% from its 52-week high of $2.37 following a catastrophic January 2026 dilution event and poor mid-cohort REMAIN-1 data. Near-term catalysts include REVEAL-1 one-year open-label readout (June 4, 2026 — strong: 78% weight loss retention at one year), Q3 2026 REMAIN-1 Midpoint Cohort topline, early Q4 2026 REMAIN-1 Pivotal Cohort six-month data, and a potential late-Q4 2026 FDA De Novo submission. Cash runway extends into early 2027 per management, but the company flagged going-concern risk in its 10-Q.",
      "verdict": "promising",
      "confidence": 4,
      "tool_calls": 25,
      "walltime_min": 47,
      "debug_path": "dossiers/2026-06-11-GUTS.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "GUTS",
    "call": "SELL",
    "confidence": 2,
    "score": -3,
    "factors": {
      "below_200dma": "-2",
      "above_50dma": "+1",
      "momentum_strong_down": "-2 (-45.9%)",
      "rsi_neutral": "0 (53.7)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (3d ago)",
      "broken_below_high": "-2 (-65.1% from high)"
    },
    "summary": "SELL (score -3) · 12-1 mom -45.9% · RSI 53.7 · above_50_only · -65.1% from high",
    "last_close": 0.83,
    "one_month_ago_close": 0.92,
    "twelve_month_ago_close": 1.7,
    "twelve_one_momentum_pct": -45.88,
    "rsi_14": 53.7,
    "ma_stack": "above_50_only",
    "from_period_high_pct": -65.11,
    "period_high": 2.37,
    "price_targets": {
      "bear": 1.09,
      "fair": 2.27,
      "bull": 8,
      "bear_return_pct": 31.8,
      "fair_return_pct": 174.4,
      "bull_return_pct": 867.4,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 2,
        "target_mean": 5.24,
        "target_high": 8,
        "analyst_count": 5
      }
    },
    "generated_at": "2026-06-24T07:36:48.491Z"
  }
}